Talaris Therapeutics Overview

Talaris Therapeutics Other Income Expense Net

Other Income/Expense Net for TALS.

Quarterly Other Income/Expense

$2.88M

↓ 35.73% YoY

As of Jun 30, 2025

Annual Other Income/Expense (TTM)

$21.66M

↑ 1259.1% YoY

Trailing 12 months ending Jun 30, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin